Human L-interleukin 4 (Hu IL-4) ELISA quantifies Hu IL-4 in human serum, plasma, buffered solution or cell culture medium. The dosage will recognize only natural and recombinant l'IL-4 Hu. Principle of the method The...
Human L-interleukin 4 (Hu IL-4) ELISA quantifies Hu IL-4 in human serum, plasma, buffered solution or cell culture medium. The dosage will recognize only natural and recombinant l'IL-4 Hu. Method principle The ELISA solid phase sandwich test of human IL-4 (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
L-interleukin-4 (IL-4) is a pleiotropic and immunomodulatory cytokine produced by activated T cells and serves as a ligand for the interleukin 4 receptor. It was found that IL-4 has the widest capacity of actions. The interleukin 4 receptor also binds to l'IL13, which can contribute to many overlapping functions of this cytokine and l'IL13. It has been shown that STAT6, a signal transducer and a transcription activator, plays an important role in mediating the immune control signal of l'IL-4. The IL-4, IL-3, IL-5, IL-13, and CSF2 genes form a group of cytokines on chromosome 5q. In particular, l In addition, genes IL-4, IL13 and IL5 are coordinated by several long-capacity regulation elements over a capacity of 120 kilobases on the chromosome. IL-4 delta 2 is a known splicing variant of l的IL-4. Order information
Shipping conditions: Wet ice
Measurement range
Dose range: 7.8-500 pg/ml.
Duration of dosing
Total duration of dosing: 3 hours.
Reproducibility
Coefficient of variation in intra-dose 3%, inter-dose 4.5%.
Samples
Sample type: Serum, Surnatant, Surnatant (plasma volume, 100 μl; serum, 100 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10521475 |
| Specifications |
| Accession number | P05112 |
| Dose range | 7.8-500 pg/ml |
| Sensitivity of the dosage | <2 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Surnatant |
| Target species | Human |
| For use with (application) | Colorimetric |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3565 |
| Gene symbol(s) | BCGF-1,BCGF1,BSF-1,BSF1,IL-4 |
| Coefficient of inter-dose variation | 4.5% |
| Coefficient of intra-dose variation | 3% |
| Contents of kits | 96-well pre-coated plate, Streptavidine-HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Accuracy | <2 pg/ml |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 100 μl; serum, 100 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h |
Origin and customs
| Manufacturer ref. | KHC0041 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.